Pay in 4 interest-free payments of $5.56 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
As of April 2026, CJC-1295 and Ipamorelin have been removed from the Food and Drug Administrations (FDA) Category 2 restricted list, with formal review of compounding eligibility scheduled for July 2026
Curr Opin Endocrinol Diabetes Obes 17:446452
It is prepared in accordance with Section 503A of the Federal Food, Drug, and Cosmetic Act and is dispensed solely pursuant to a valid patient-specific prescription from a licensed healthcare provider
And do they also risk their health
Learn more about CJC-1295 DAC here, including the various formulations on offer from Direct Peptides
US$ 21.65
US$ 29.46
US$ 26.53
US$ 28.59
US$ 22.68
US$ 24.49
US$ 20.31
US$ 26.76
US$ 27.62
